Emil T. Kuriakose
Corporate Officer/Principal chez TERNS PHARMACEUTICALS, INC.
Fortune : 272 684 $ au 30/04/2024
Provenance du réseau au premier degré de Emil T. Kuriakose
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 18 | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Emil T. Kuriakose via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Operating Officer | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact Corporate Officer/Principal General Counsel | |
| NOVARTIS AG | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
| NIGHTSTAR THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO General Counsel | |
| University of California San Diego | College/University | Doctorate Degree Undergraduate Degree | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor Consultant / Advisor | |
| THESEUS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
OrbiMed Advisors LLC
 OrbiMed Advisors LLC Investment ManagersFinance OrbiMed Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. It was founded by Sven Borho and Carl Gordon in 1989. The firm provides discretionary investment management services to US and non-US public and private funds. | Investment Managers | Founder Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| CENTREXION THERAPEUTICS CORPORATION | Pharmaceuticals: Major | Founder Director/Board Member | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| TURG POIN | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
| VIRACTA THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Pennsylvania | College/University | Corporate Officer/Principal | |
| RIGEL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| KURA ONCOLOGY, INC. | Biotechnology | Director/Board Member | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GlaxoSmithKline (New Jersey) | Corporate Officer/Principal | ||
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
| University of the Witwatersrand | College/University | Doctorate Degree | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Chief Executive Officer | |
npower
 npower Miscellaneous Commercial ServicesCommercial Services Npower is a national nonprofit organization that aims to move people from poverty to the middle class by providing free, six-month training programs to youth from underserved communities and military-connected individuals in a range of tech skills. The non-profit company is based in Brooklyn, NY. The program offers industry-recognized certifications and places students in paid internships with corporate and nonprofit organizations. The CEO of the company is Bertina Ceccarelli. | Miscellaneous Commercial Services | Director/Board Member | |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| RAFAEL HOLDINGS, INC. | Real Estate Development | Chief Executive Officer | |
| University of Wisconsin | College/University | Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Graduate Degree | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Cornerstone Pharmaceuticals, Inc.
 Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Miscellaneous Commercial Services | Chairman | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Executive Officer | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal | |
Ichnos Sciences, Inc.
 Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistiques
Internationale
| Etats-Unis | 41 |
| Royaume-Uni | 3 |
| Suisse | 3 |
| France | 3 |
| Israël | 2 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 159 |
| Corporate Officer/Principal | 93 |
| Independent Dir/Board Member | 49 |
| Undergraduate Degree | 23 |
| Chief Executive Officer | 21 |
Relations les plus connectées
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Jeffrey Kindler | 48 |
| Hong Bo Lu | 28 |
| David Fellows | 16 |
| Steven Baert | 16 |
| Alessandro Riva | 14 |
| Lisa Rojkjaer | 12 |
| Amy Burroughs | 12 |
| Jill Quigley | 11 |
| Hugh O'Dowd | 11 |
| Herve Hoppenot | 11 |
| Bruno Strigini | 10 |
| Ameet Mallik | 10 |
| Steven Stein | 9 |
| Mark Vignola | 9 |
- Bourse
- Insiders
- Emil T. Kuriakose
- Connexions Sociétés
